CSIMarket
 
Revolution Medicines Inc   (NASDAQ: RVMD)
 
Price: $200.4150 $-4.45 -2.170%
Day's High: $205.14999389648438 Week Perf: -1.44 %
Day's Low: $ 199.04 30 Day Perf: -5.46 %
Volume (M): 392,231 52 Wk High: $ 224.31
Volume (M$): $ 0 52 Wk Avg: $121.78
Open: $205.13 52 Wk Low: $42.18



 Market Capitalization (Millions $) 42,266
 Shares Outstanding (Millions) 211
 Employees 883
 Revenues (TTM) (Millions $) -
 Net Income (TTM) (Millions $) -1,768
 Cash Flow (TTM) (Millions $) 39
 Capital Exp. (TTM) (Millions $) 9

Business Description


Revolution Medicines Inc is a biopharmaceutical company that specializes in the discovery and development of new medicines targeting frontier oncology and inflammatory diseases. The company utilizes a proprietary integrated technology platform to identify novel molecules and develop therapies that could potentially transform patients' lives.

Revolution Medicines focuses on targeting elusive and challenging signaling pathways within cancer cells through precision medicines. By identifying and inhibiting these unique oncogenic targets, the company aims to disrupt the progression of cancer and improve patient outcomes.

The company's approach involves a deep understanding of the underlying biology of diseases and the development of small molecule inhibitors that can selectively interrupt disease-causing pathways. Revolution Medicines' research and development efforts are guided by a combination of molecular understanding, computational biology, and medicinal chemistry expertise.

With a goal of developing breakthrough medicines, Revolution Medicines collaborates with academic institutions, biotech partners, and pharmaceutical companies to advance its drug candidates into clinical trials. The company has a pipeline of various targeted therapies in different stages of development, with a focus on treating cancers that have limited treatment options.

In summary, Revolution Medicines Inc is a biopharmaceutical company that aims to revolutionize the treatment of cancer and inflammatory diseases by developing precision medicines that target specific disease-causing pathways. Through its innovative approaches and collaborations, the company seeks to provide better therapeutic options to patients in need.


   Company Address: 700 Saginaw Drive Redwood City 94063 CA
   Company Phone Number: 481-6801   Stock Exchange / Ticker: NASDAQ RVMD


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
AMGN   -4.11%    
BCRX   -6.81%    
EXEL   -2.09%    
GILD        1.14% 
HALO   -0.7%    
STRO   -11.27%    
• View Complete Report
   



Clinical Study

Revolution Medicines Advances RAS-Targeted Therapies in Oncology Third Quarter Financial Results and Clinical Updates

Published Thu, Nov 6 2025 8:20 AM UTC

for CSIMarket.com Revolution Medicines, Inc., a late-stage clinical oncology company based in Redwood City, California, recently reported its financial results for the third quarter of 2025 and provided significant updates on its pipeline of targeted therapies aimed at treating RAS-addicted cancers. Financial Overview For the quarter ending September 30, 2025, Revoluti...

Product Service News

Promising Advances in Targeted Therapy for Metastatic Pancreatic Ductal Adenocarcinoma Insights from the RASolute 303...

Published Wed, Sep 10 2025 8:04 PM UTC

Metastatic pancreatic ductal adenocarcinoma (mPDAC) remains one of the most challenging malignancies to treat, often associated with poor prognosis and limited therapeutic options. Revolution Medicines Inc. has recently announced new clinical results supporting the initiation of RASolute 303, a global Phase 3 registrational trial of daraxonrasib in patients with first-line ...

Shares

Revolution Medicines Strategic Public Offering: A $862.5 Million Boost and Its Implications for Shareholders

Published Thu, Dec 5 2024 9:06 PM UTC

Revolution Medicines, Inc. Announces Successful Completion of Upsized Public OfferingIn a significant development for Revolution Medicines, Inc. (NASDAQ: RVMD), the company recently announced the successful closing of an upsized public offering of common stock and pre-funded warrants. This strategic move not only showcases the company’s robust financial health, but it also...

Stock Market Announcement

Revolution Medicines to Revolutionize Cancer Therapy with Strategic $750 Million Offering,

Published Wed, Dec 4 2024 3:39 AM UTC

Revolution Medicines: A Powerful Upsized Offering Set to Fuel GrowthRevolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company dedicated to developing cutting-edge treatments for RAS-addicted cancers, recently announced the pricing of an upsized $750 million public offering. This strategic move marks a pivotal moment for the company, undoubtedly propelling ...

Stock Market Announcement

Revolution Medicines: Strategic Public Offering Aims to Fuel Future Growth in RAS-Targeted Cancer Therapies

Published Mon, Dec 2 2024 9:31 PM UTC

In a bold step towards accelerating its mission to revolutionize cancer therapy, Redwood City-based Revolution Medicines Inc. (Nasdaq: RVMD) announced on December 2, 2024, its decision to commence an ambitious underwritten public offering. The company, at the forefront of developing targeted treatments for RAS-addicted cancers a notoriously challenging and impactful area of ...




Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) -
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) -
Price to Sales (Expected) -
Price to Book 16.22
PEG (TTM) -

Financial Strength Current
Quick Ratio 5.54
Working Capital Ratio 5.67
Leverage Ratio (MRQ) 0.66
Total Debt to Equity 0.19
Interest Coverage (TTM) -
Debt Coverage (TTM) -

Per Share Current
Earnings (TTM) -8.88 $
Revenues (TTM) -
Cash Flow (TTM) 0.19 $
Cash 18.67 $
Book Value 12.36 $
Dividend (TTM) 0 $

Efficiency Current
Revenue per Employee (TTM) -
Net Income per Employee (TTM) -2,002,588
Receivable Turnover Ratio (TTM) -
Inventory Turnover Ratio (TTM) -
Asset Turnover Ratio (TTM) -

Profitability Ratios Current
Gross Margin (MRQ) -
Operating Margin (MRQ) -
Net Margin (MRQ) -
Net Cash Flow Margin (MRQ) -
Effective Tax Rate (TTM) -

Management Effectiveness Current
Return On Assets (TTM) -
Return On Investment (TTM) -
Return On Equity (TTM) -
Dividend Yield -
Pay out Ratio (TTM) -






Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.